BBS Bioactive (Finland) Buy Hold or Sell Recommendation
| BONEH Stock | EUR 0.07 0 4.23% |
Assuming the 90 days trading horizon and your bold attitude towards risk, our recommendation regarding BBS Bioactive Bone Substitutes is 'Strong Sell'. The recommendation algorithm takes into account all of BBS Bioactive's available fundamental, technical, and predictive indicators you will find on this site.
Check out BBS Bioactive Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as BBS and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards BBS Bioactive Bone Substitutes. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
BBS |
Execute BBS Bioactive Buy or Sell Advice
The BBS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BBS Bioactive Bone Substitutes. Macroaxis does not own or have any residual interests in BBS Bioactive Bone Substitutes or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BBS Bioactive's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
BBS Bioactive Trading Alerts and Improvement Suggestions
| BBS Bioactive Bone generated a negative expected return over the last 90 days | |
| BBS Bioactive Bone has high historical volatility and very poor performance | |
| BBS Bioactive Bone has some characteristics of a very speculative penny stock | |
| BBS Bioactive Bone has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.77 M) with loss before overhead, payroll, taxes, and interest of (56.95 K). | |
| BBS Bioactive Bone Substitutes has accumulated about 3.44 M in cash with (2.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 46.0% of the company shares are held by company insiders |
BBS Bioactive Returns Distribution Density
The distribution of BBS Bioactive's historical returns is an attempt to chart the uncertainty of BBS Bioactive's future price movements. The chart of the probability distribution of BBS Bioactive daily returns describes the distribution of returns around its average expected value. We use BBS Bioactive Bone Substitutes price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BBS Bioactive returns is essential to provide solid investment advice for BBS Bioactive.
| Mean Return | -1.71 | Value At Risk | -9.09 | Potential Upside | 6.67 | Standard Deviation | 9.04 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BBS Bioactive historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BBS Bioactive Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BBS Bioactive or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BBS Bioactive's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BBS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.38 | |
β | Beta against Dow Jones | -3.28 | |
σ | Overall volatility | 9.12 | |
Ir | Information ratio | -0.2 |
BBS Bioactive Volatility Alert
BBS Bioactive Bone Substitutes is displaying above-average volatility over the selected time horizon. BBS Bioactive Bone Substitutes is a penny stock. Although BBS Bioactive may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in BBS Bioactive Bone Substitutes. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on BBS instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.BBS Bioactive Fundamentals Vs Peers
Comparing BBS Bioactive's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BBS Bioactive's direct or indirect competition across all of the common fundamentals between BBS Bioactive and the related equities. This way, we can detect undervalued stocks with similar characteristics as BBS Bioactive or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BBS Bioactive's fundamental indicators could also be used in its relative valuation, which is a method of valuing BBS Bioactive by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BBS Bioactive to competition |
| Fundamentals | BBS Bioactive | Peer Average |
| Return On Equity | -0.61 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Operating Margin | (278.58) % | (5.51) % |
| Current Valuation | 14.53 M | 16.62 B |
| Shares Outstanding | 9.67 M | 571.82 M |
| Shares Owned By Insiders | 45.74 % | 10.09 % |
| Shares Owned By Institutions | 1.71 % | 39.21 % |
| Price To Book | 2.10 X | 9.51 X |
| Price To Sales | 1,123 X | 11.42 X |
| Gross Profit | (56.95 K) | 27.38 B |
| EBITDA | (2.34 M) | 3.9 B |
| Net Income | (2.77 M) | 570.98 M |
| Cash And Equivalents | 3.44 M | 2.7 B |
| Cash Per Share | 0.52 X | 5.01 X |
| Total Debt | 5.12 M | 5.32 B |
| Debt To Equity | 0.99 % | 48.70 % |
| Current Ratio | 5.04 X | 2.16 X |
| Book Value Per Share | 0.58 X | 1.93 K |
| Cash Flow From Operations | (2.52 M) | 971.22 M |
| Earnings Per Share | (0.42) X | 3.12 X |
| Number Of Employees | 21 | 18.84 K |
| Beta | -0.0943 | -0.15 |
| Market Capitalization | 12.23 M | 19.03 B |
| Total Asset | 10.51 M | 29.47 B |
| Z Score | 1.2 | 8.72 |
| Net Asset | 10.51 M |
BBS Bioactive Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BBS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BBS Bioactive Buy or Sell Advice
When is the right time to buy or sell BBS Bioactive Bone Substitutes? Buying financial instruments such as BBS Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BBS Bioactive in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Artificial Intelligence Thematic Idea Now
Artificial Intelligence
Technology companies, funds, and ETFs across multiple industries that are involved in research or development in the field of reasoning, learning, natural language processing and perception as well as its application to science and commerce. This theme may also include entities involved in cybernetics and cognitive brain simulation field. The Artificial Intelligence theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Artificial Intelligence Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BBS Stock
BBS Bioactive financial ratios help investors to determine whether BBS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BBS with respect to the benefits of owning BBS Bioactive security.